Dr. Kashinath G. Yadalam

Psychiatry
St Paul Companion Care LLC
1 Lakeshore Dr Ste 1695, 
Lake Charles, LA 
St Paul Companion Care LLC
1 Lakeshore Dr Ste 1695, 
Lake Charles, LA 

Overview

Kashinath Yadalam is a Psychiatrist practicing medicine in Lake Charles, Louisiana.

His clinical expertise encompasses Autism Spectrum Disorder and Alzheimer's Disease.

He is actively involved in clinical research, participating in 7 clinical trials.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in LA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

St Paul Companion Care LLC
1 Lakeshore Dr Ste 1695, Lake Charles, LA 70629

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2026
Intervention Type: Drug
Study Drug: CM-AT Enzyme
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Enrollment Status: Completed
Publish Date: July 31, 2024
Intervention Type: Drug, Other
Study Drug: Bryostatin I
Study Phase: Phase 2
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Enrollment Status: Completed
Publish Date: October 01, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

Office

1710 Evangeline Hwy, 
Jennings, LA 
 (31.9 miles away)
337-824-7278
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Charles Bramlet is a Psychiatrist practicing medicine in Jennings, Louisiana. Dr. Bramlet is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), Bipolar Disorder (BPD), Major Depression, and Schizoaffective Disorder. Dr. Bramlet is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

Institute For Neuropsychiatry Apmc

2829 4th Ave Ste 150, 
Lake Charles, LA 
 (1.2 miles away)
337-477-7091
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Said Cantu is a Psychiatrist practicing medicine in Lake Charles, Louisiana. Dr. Cantu is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Major Depression, Dementia, Seasonal Affective Disorder (SAD), and Schizoaffective Disorder. Dr. Cantu is currently accepting new patients.

Expertise in
5
conditions
Expertise in
5
conditions
Referral may be required

Psychiatric Center LLC

324 W Hale St, 
Lake Charles, LA 
 (1.4 miles away)
337-433-9177
Languages Spoken:
English
See accepted insurances

Ehtesham Syed is a Psychiatrist practicing medicine in Lake Charles, Louisiana. Dr. Syed is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Bipolar Disorder (BPD), Schizoaffective Disorder, Schizophrenia, and Major Depression.

Frequently Asked Questions about Dr. Kashinath G. Yadalam

How do I make an appointment with Dr. Kashinath G. Yadalam?

You can book an appointment with Dr. Kashinath G. Yadalam by calling their office at 337-564-6405. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kashinath G. Yadalam a top-rated expert for Autism Spectrum Disorder?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kashinath G. Yadalam is classified as an Experienced expert for Autism Spectrum Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kashinath G. Yadalam specialize in?

While Dr. Kashinath G. Yadalam is a Psychiatry, they have specific expertise in Autism Spectrum Disorder, Alzheimer's Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Kashinath G. Yadalam accept my insurance?

Dr. Kashinath G. Yadalam accepts most major insurance plans, including Aetna. We recommend calling the office directly at 337-564-6405 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yadalam's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile